SCHEMBL6537532

SCHEMBL6537532

N#Cc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1N1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.51
KDM4E B2RXH2 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TSHR P16473 1/20 0.46
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 2/20 0.43
RXFP1 Q9HBX9 1/20 0.42
CHRM4 P08173 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
EPHB3 P54753 1/20 0.41
WDR5 P61964 1/20 0.41
THRB P10828 1/20 0.41
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
JAK3 P52333 1/20 0.40
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538059 0.89 LCK (0.47) TP53KDM4EALDH1A1HTTUSP2
SCHEMBL6537691 0.85 HSD17B10 (0.50) TP53KDM4EHSD17B10TSHRALDH1A1
SCHEMBL6537716 0.84 HSD17B10 (0.52) TP53KDM4EHSD17B10TSHRALDH1A1
SCHEMBL6537601 0.84 HSD17B10 (0.49) TP53KDM4EHSD17B10TSHRALDH1A1
SCHEMBL6537383 0.81 TAS1R3 (0.46) TP53KDM4EHSD17B10TSHRALDH1A1
SCHEMBL6537641 0.79 HSD17B10 (0.54) TP53KDM4EHSD17B10TSHRALDH1A1
SCHEMBL6538372 0.79 MAPK1 (0.66) TP53KDM4EHSD17B10TSHRALDH1A1
SCHEMBL6537802 0.79 CYP3A4 (0.45) KMT2AHTTSMN1; SMN2EPHB3CYP1A2
SCHEMBL6537599 0.79 TAS1R3 (0.44) TP53KDM4EHSD17B10TSHRALDH1A1
SCHEMBL6537745 0.78 TAS1R3 (0.42) TP53KDM4EHSD17B10TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed